{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:39:06Z","timestamp":1779392346680,"version":"3.53.1"},"reference-count":34,"publisher":"Baskent University","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.6002\/ect.2024.0085","type":"journal-issue","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:47:37Z","timestamp":1724402857000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Liu JZ, Hov JR, Folseraas T, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45(6):670-675. doi:10.1038\/ng.2616","DOI":"10.1038\/ng.2616"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510-518. doi:10.1038\/ng.3528","DOI":"10.1038\/ng.3528"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Ji SG, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49(2):269-273. doi:10.1038\/ng.3745","DOI":"10.1038\/ng.3745"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Boonstra K, van Erpecum KJ, van Nieuwkerk KM, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2270-2276. doi:10.1002\/ibd.22938","DOI":"10.1002\/ibd.22938"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006;44(3):746-764. doi:10.1002\/hep.21337","DOI":"10.1002\/hep.21337"},{"key":"ref5","unstructured":"6. Feldman M, Friedman, LS., Brandt, LJ. . Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2020."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kotlyar DS, Campbell MS, Reddy KR. Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol. 2006;101(6):1370-1378. doi:10.1111\/j.1572-0241.2006.00586.x","DOI":"10.1111\/j.1572-0241.2006.00586.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet. 2002;360(9349):1943-1944. doi:10.1016\/S0140-6736(02)11861-7","DOI":"10.1016\/S0140-6736(02)11861-7"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Dvorchik I, Subotin M, Demetris AJ, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology. 2002;35(2):380-384. doi:10.1053\/jhep.2002.30695","DOI":"10.1053\/jhep.2002.30695"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Brandsaeter B, Schrumpf E, Bentdal O, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl. 2005;11(11):1361-1369. doi:10.1002\/lt.20444","DOI":"10.1002\/lt.20444"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Jeyarajah DR, Netto GJ, Lee SP, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation. 1998;66(10):1300-1306. doi:10.1097\/00007890-199811270-00006","DOI":"10.1097\/00007890-199811270-00006"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. European Association for the Study of the Liver Disease. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-267. doi:10.1016\/j.jhep.2009.04.009","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Guerra I, Bujanda L, Castro J, et al. Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study. J Crohns Colitis. 2019;13(12):1492-1500. doi:10.1093\/ecco-jcc\/jjz094","DOI":"10.1093\/ecco-jcc\/jjz094"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ahmed M. Acute cholangitis - an update. World J Gastrointest Pathophysiol. 2018;9(1):1-7. doi:10.4291\/wjgp.v9.i1.1","DOI":"10.4291\/wjgp.v9.i1.1"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kremer AE, Namer B, Bolier R, Fischer MJ, Oude Elferink RP, Beuers U. Pathogenesis and management of pruritus in PBC and PSC. Dig Dis. 2015;33(Suppl 2):164-175. doi:10.1159\/000440829","DOI":"10.1159\/000440829"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol. 2004;39(10):961-968. doi:10.1080\/00365520410003434","DOI":"10.1080\/00365520410003434"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Angulo P, Grandison GA, Fong DG, et al. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology. 2011;140(1):180-188. doi:10.1053\/j.gastro.2010.10.014","DOI":"10.1053\/j.gastro.2010.10.014"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology. ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110(5):646-659. doi:10.1038\/ajg.2015.112","DOI":"10.1038\/ajg.2015.112"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology. 1983;149(1):39-44. doi:10.1148\/radiology.149.1.6412283","DOI":"10.1148\/radiology.149.1.6412283"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Bangarulingam SY, Gossard AA, Petersen BT, Ott BJ, Lindor KD. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104(4):855-860. doi:10.1038\/ajg.2008.161","DOI":"10.1038\/ajg.2008.161"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48(4):1106-1117. doi:10.1002\/hep.22441","DOI":"10.1002\/hep.22441"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. European Society of Gastrointestinal Endoscopy, European Association for the Study of the Liver. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) clinical guideline. J Hepatol. 2017;66(6):1265-1281. doi:10.1016\/j.jhep.2017.02.013","DOI":"10.1016\/j.jhep.2017.02.013"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Hildebrand T, Pannicke N, Dechene A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transpl. 2016;22(1):42-52. doi:10.1002\/lt.24350","DOI":"10.1002\/lt.24350"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Ravikumar R, Tsochatzis E, Jose S, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol. 2015;63(5):1139-1146. doi:10.1016\/j.jhep.2015.07.005","DOI":"10.1016\/j.jhep.2015.07.005"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Cholongitas E, Shusang V, Papatheodoridis GV, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14(2):138-143. doi:10.1002\/lt.21260","DOI":"10.1002\/lt.21260"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Lindstrom L, Jorgensen KK, Boberg KM, et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic multicentre study. Scand J Gastroenterol. 2018;53(3):297-304. doi:10.1080\/00365521.2017.1421705","DOI":"10.1080\/00365521.2017.1421705"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14(2):245-251. doi:10.1002\/lt.21394","DOI":"10.1002\/lt.21394"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Moncrief KJ, Savu A, Ma MM, Bain VG, Wong WW, Tandon P. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience. Can J Gastroenterol. 2010;24(1):40-46. doi:10.1155\/2010\/830291","DOI":"10.1155\/2010\/830291"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg. 1997;225(5):472-481; discussion 481-473. doi:10.1097\/00000658-199705000-00004","DOI":"10.1097\/00000658-199705000-00004"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Campsen J, Zimmerman MA, Trotter JF, et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl. 2008;14(2):181-185. doi:10.1002\/lt.21313","DOI":"10.1002\/lt.21313"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, et al. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation. Aliment Pharmacol Ther. 2019;49(6):636-643. doi:10.1111\/apt.15148","DOI":"10.1111\/apt.15148"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Trivedi PJ, Reece J, Laing RW, et al. The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2018;48(3):322-332. doi:10.1111\/apt.14828","DOI":"10.1111\/apt.14828"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Visseren T, Erler NS, Heimbach JK, et al. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study. JHEP Rep. 2022;4(12):100599. doi:10.1016\/j.jhepr.2022.100599","DOI":"10.1016\/j.jhepr.2022.100599"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Shamsaeefar A, Shafiee M, Nikeghbalian S, et al. Biliary reconstruction in liver transplant patients with primary sclerosing cholangitis, duct\u2010to\u2010duct or Roux\u2010en\u2010Y? Clin Transplant. 2017;31(6). doi:10.1111\/ctr.12964","DOI":"10.1111\/ctr.12964"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:10:51Z","timestamp":1724404251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2024\/22\/7\/0\/531\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2024.0085","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}